Bevacizumab Beyond Progression (BBP)

Clinical trial NCT01740258 · COMPLETED

Trial details

NCT number: NCT01740258
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Glioma Grade 4 Malignant Glioma Glioblastoma Gliosarcoma

Start date: 2013-01-01
Primary completion: 2019-11-14
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.